ReviewDrugs & aging2019

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer.

Yara van Holstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.